000 01374 a2200373 4500
005 20250517172252.0
264 0 _c20180619
008 201806s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-16-3065
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnagnostou, Valsamo
245 0 0 _aImmuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_c09 2017
300 _a4959-4969 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aBiomarkers
650 0 4 _aBiomarkers, Tumor
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xtrends
650 0 4 _aMedical Oncology
_xtrends
650 0 4 _aNeoplasms
_xdrug therapy
700 1 _aYarchoan, Mark
700 1 _aHansen, Aaron R
700 1 _aWang, Hao
700 1 _aVerde, Franco
700 1 _aSharon, Elad
700 1 _aCollyar, Deborah
700 1 _aChow, Laura Q M
700 1 _aForde, Patrick M
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 23
_gno. 17
_gp. 4959-4969
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-16-3065
_zAvailable from publisher's website
999 _c27520937
_d27520937